Plant-derived extracellular vesicles -a novel clinical anti-inflammatory drug carrier worthy of investigation

Biomed Pharmacother. 2023 Dec 31:169:115904. doi: 10.1016/j.biopha.2023.115904. Epub 2023 Nov 18.

Abstract

Plant-derived extracellular vesicles (PDEVs) have shown remarkable potential as sustainable, green, and efficient drug delivery nanocarriers. As natural nanoparticles containing lipids, protein, nucleic acids and secondary metabolites, they have received widespread attention as a replacement for mammalian exosomes in recent years. In this review, the advances in isolation, identification, composition, therapeutic effect, and clinical application prospect were comprehensively reviewed, respectively. In addition, the specific modification strategies have been listed focusing on the inherent drawbacks of the raw PDEVs like low targeting efficiency and poor homogeneity. With emphasis on their biology mechanism in terms of immune regulation, regulating oxidative stress and promoting regeneration in the anti-inflammatory field and application value demonstrated by citing some typical examples, this review about PDEVs would provide a broad and fundamental vision for the in-depth exploration and development of plant-derived extracellular vesicles in the in-vivo anti-inflammation and even other biomedical applications.

Keywords: Anti-inflammation; Cargo loading; Exosomes; Plant-derived extracellular vesicles.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Drug Carriers
  • Drug Delivery Systems
  • Exosomes*
  • Extracellular Vesicles*
  • Mammals

Substances

  • Anti-Inflammatory Agents
  • Drug Carriers